A Study of LY2835219 in Healthy Participants
NCT02059148
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
LY2835219
Sponsor
Eli Lilly and Company